Literature DB >> 26629173

Correlation between body mass index and clinicopathological features of papillary thyroid microcarcinoma.

Zeming Liu1, Yusufu Maimaiti1, Pan Yu1, Yiquan Xiong1, Wen Zeng2, Xiaoyu Li1, Haiping Song1, Chong Lu1, Yue Xin1, Jing Zhou1, Ning Zhang1, Jie Ming1, Chunping Liu1, Wei Shi1, Lan Shi1, Xueqin Li1, Xiu Nie3, Tao Huang1.   

Abstract

OBJECTIVES: To demonstrate the relationships between body mass index (BMI) and the clinicopathological features of papillary thyroid microcarcinoma (PTMC) and papillary thyroid carcinoma (PTC).
METHODS: A total of 810 consecutive patients with PTC (501 patients with PTMC) who underwent total thyroidectomy in 2009-2013 were retrospectively reviewed. Height and weight were used to calculate BMI.
RESULTS: Increased BMI was strongly associated with i) extrathyroidal invasion (P < 0.001) and advanced TNM stage (P = 0.005) in patients with PTMC (n = 501), and ii) extrathyroidal invasion (P = 0.001), advanced TNM stage (P = 0.001), and multifocality (P = 0.002) in patients with PTC (n = 810). As compared with normal-weight patients with PTMC, obese patients with PTMC had greater risks of extrathyroidal invasion (OR = 5.214, P = 0.0270), and overweight patients with PTMC had greater risks of extrathyroidal invasion (OR = 2.165, P = 0.0013) and advanced TNM stage (OR = 2.019, P = 0.0137). As compared with normal-weight patients with PTC, obese patients with PTC had greater risks of extrathyroidal invasion (OR = 3.101, P = 0.0172), and overweight patients with PTC had greater risks of extrathyroidal invasion (OR = 1.486, P = 0.0279), advanced TNM stage (OR = 1.650, P = 0.0347), and multifocality (OR = 1.651, P = 0.0054).
CONCLUSIONS: Increased BMI might elevate the risks of aggressive clinicopathological features, such as extrathyroidal invasion and advanced TNM stage. Obesity control may play an important role in preventing the development of aggressive PTMCs and all PTCs.

Entities:  

Keywords:  Body mass index; prognosis; thyroid papillary microcarcinoma

Year:  2015        PMID: 26629173      PMCID: PMC4659061     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  33 in total

1.  Histological typing of thyroid tumours.

Authors:  L H Sobin
Journal:  Histopathology       Date:  1990-05       Impact factor: 5.087

2.  Increasing incidence of thyroid cancer in the United States, 1973-2002.

Authors:  Louise Davies; H Gilbert Welch
Journal:  JAMA       Date:  2006-05-10       Impact factor: 56.272

3.  Multifocality and total tumor diameter predict central neck lymph node metastases in papillary thyroid microcarcinoma.

Authors:  Qunzi Zhao; Jie Ming; Chunping Liu; Lan Shi; Xia Xu; Xiu Nie; Tao Huang
Journal:  Ann Surg Oncol       Date:  2012-09-13       Impact factor: 5.344

4.  Obesity and excess protein and carbohydrate consumption are risk factors for thyroid cancer.

Authors:  Marjory Alana Marcello; Aline Castaldi Sampaio; Bruno Geloneze; Ana Carolina Junqueira Vasques; Ligia Vera Montalli Assumpção; Laura Sterian Ward
Journal:  Nutr Cancer       Date:  2012       Impact factor: 2.900

5.  Routine central compartment lymph node dissection for patients with papillary thyroid carcinoma.

Authors:  David I Kutler; Audrey D Crummey; William I Kuhel
Journal:  Head Neck       Date:  2011-03-17       Impact factor: 3.147

6.  Correlation between obesity and clinicopathological factors in patients with papillary thyroid cancer.

Authors:  Shin-Hyuk Kim; Hyung Seok Park; Ki-Ho Kim; Ho Yoo; Byung-Joo Chae; Ja-Seong Bae; Sang-Seol Jung; Byung-Joo Song
Journal:  Surg Today       Date:  2014-07-25       Impact factor: 2.549

Review 7.  Reducing the weight of cancer: mechanistic targets for breaking the obesity-carcinogenesis link.

Authors:  Stephen D Hursting; Laura M Lashinger; Karrie W Wheatley; Connie J Rogers; Lisa H Colbert; Nomeli P Nunez; Susan N Perkins
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2008-08       Impact factor: 4.690

8.  Body mass index in the evaluation of thyroid cancer risk.

Authors:  Tamara Mijović; Jacques How; Michael Pakdaman; Louise Rochon; Olguta Gologan; Michael P Hier; Martin J Black; Jonathan Young; Michael Tamilia; Richard J Payne
Journal:  Thyroid       Date:  2009-05       Impact factor: 6.568

Review 9.  Obesity and prostate cancer: epidemiology and clinical implications.

Authors:  W Cooper Buschemeyer; Stephen J Freedland
Journal:  Eur Urol       Date:  2007-05-02       Impact factor: 20.096

10.  Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5·24 million UK adults.

Authors:  Krishnan Bhaskaran; Ian Douglas; Harriet Forbes; Isabel dos-Santos-Silva; David A Leon; Liam Smeeth
Journal:  Lancet       Date:  2014-08-13       Impact factor: 79.321

View more
  8 in total

1.  Associations between BRAF(V600E) and prognostic factors and poor outcomes in papillary thyroid carcinoma: a meta-analysis.

Authors:  Chunping Liu; Tianwen Chen; Zeming Liu
Journal:  World J Surg Oncol       Date:  2016-09-06       Impact factor: 2.754

2.  Pretreatment BMI Is Associated with Aggressive Clinicopathological Features of Papillary Thyroid Carcinoma: A Multicenter Study.

Authors:  Shi-Tong Yu; Wanzhi Chen; Qian Cai; Faya Liang; Debin Xu; Ping Han; Jichun Yu; Xiaoming Huang
Journal:  Int J Endocrinol       Date:  2017-09-20       Impact factor: 3.257

3.  Associations between body mass index and lymph node metastases of patients with papillary thyroid cancer: A retrospective study.

Authors:  Changhua Wu; Liang Wang; Wanjun Chen; Shujuan Zou; Aiju Yang
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

4.  Potential Impact of Body Mass Index on the Clinical Outcome of Papillary Thyroid Cancer After High-Dose Radioactive Iodine Therapy.

Authors:  Jingjia Cao; Xiaolu Zhu; Yaru Sun; Xiao Li; Canhua Yun; Wei Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-26       Impact factor: 6.055

Review 5.  Association of BMI with Clinicopathological Features of Papillary Thyroid Cancer: A Systematic Review and Meta-Analysis.

Authors:  R J O'Neill; S Abd Elwahab; M J Kerin; A J Lowery
Journal:  World J Surg       Date:  2021-06-16       Impact factor: 3.352

6.  The impact of BMI on clinical progress, response to treatment, and disease course in patients with differentiated thyroid cancer.

Authors:  Danuta Gąsior-Perczak; Iwona Pałyga; Monika Szymonek; Artur Kowalik; Agnieszka Walczyk; Janusz Kopczyński; Katarzyna Lizis-Kolus; Tomasz Trybek; Estera Mikina; Dorota Szyska-Skrobot; Klaudia Gadawska-Juszczyk; Stefan Hurej; Artur Szczodry; Anna Słuszniak; Janusz Słuszniak; Ryszard Mężyk; Stanisław Góźdź; Aldona Kowalska
Journal:  PLoS One       Date:  2018-10-01       Impact factor: 3.240

Review 7.  Combinatorial Therapies in Thyroid Cancer: An Overview of Preclinical and Clinical Progresses.

Authors:  Gheysen Laetitia; Saussez Sven; Journe Fabrice
Journal:  Cells       Date:  2020-03-30       Impact factor: 6.600

8.  Association Between Aggressive Clinicopathologic Features of Papillary Thyroid Carcinoma and Body Mass Index: A Systematic Review and Meta-Analysis.

Authors:  Aliki Economides; Konstantinos Giannakou; Ioannis Mamais; Panayiotis A Economides; Panagiotis Papageorgis
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-30       Impact factor: 5.555

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.